Ki Summary

Reaction Details

Report a problem with these data

Target

Alpha-1D adrenergic receptor

Ligand

BDBM50211316

Substrate/Competitor

n/a

Meas. Tech.

ChEMBL_444278 (CHEMBL894518)

2.4±n/a nM

Citation

Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS). Bioorg Med Chem Lett17:3292-7 (2007) [PubMed] Article

More Info.:

Get all data from this article, Assay Method

Alpha-1D adrenergic receptor

Name:

Alpha-1D adrenergic receptor

Synonyms:

Type:

Enzyme Catalytic Domain

Mol. Mass.:

60485.82

Organism:

Homo sapiens (Human)

Description:

adrenergic Alpha1D ADRA1D HUMAN::P25100

Residue:

572

Sequence:

MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAG
SGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILS
VACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCC
TASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVP
PDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKAS
EVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLC
WFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQ
CRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEM
QAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVE
AVSLGVPHEVAEGATCQAYELADYSNLRETDI

BDBM50211316

n/a

Name

BDBM50211316

Synonyms:

2-fluoro-N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperazin-1-yl)cyclohexyl)benzenesulfonamide | CHEMBL399195

Type

Small organic molecule

Emp. Form.

C25H34FN3O3S

Mol. Mass.

475.619

SMILES

CC(C)Oc1ccccc1N1CCN(CC1)[C@@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccccc1F |wU:16.17,19.24,(16.96,-18.35,;16.18,-19.68,;14.64,-19.66,;16.93,-21.02,;16.14,-22.34,;14.61,-22.32,;13.82,-23.65,;14.58,-25,;16.12,-25.01,;16.9,-23.69,;18.43,-23.7,;19.19,-25.04,;20.73,-25.06,;21.51,-23.74,;20.76,-22.4,;19.22,-22.38,;23.04,-23.76,;23.8,-25.11,;25.33,-25.13,;26.12,-23.81,;25.37,-22.46,;23.83,-22.44,;27.68,-23.84,;28.45,-22.51,;27.12,-21.74,;29.78,-23.28,;29.21,-21.17,;28.44,-19.85,;29.19,-18.51,;30.74,-18.49,;31.52,-19.82,;30.76,-21.16,;31.54,-22.49,)|

Structure